BDRL
BLONDER TONGUE LABORATORIES INCCompany Information
- Company Name
- BLONDER TONGUE LABORATORIES INC
- CIK
- CIK0001000683
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BDRL: OTC
- Fiscal Year End
- December 31
- Owner Organization
- Not Available
- SIC
- 3663
- SIC Description
- Radio & Tv Broadcasting & Communications Equipment
- Ticker
- BDRL
SEC filing data through
Insider Sentiment
- Last purchase
- 2019-05-28
- Last sale
- 2021-11-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 366,545
Institutional Sentiment
- As of
- 2022-03-31
- Institutional shares owned
- 611,642
- Shares outstanding
- 12,151,000
- Ownership
- 5.03%
Earnings Market Reaction
- Filing date
- 2023-04-17
- Price on filing date
- —
- 1-month reaction
- 7.20%
- 3-month reaction
- 7.20%
Balance Sheet
Values in millions ($)| Line item | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 3 | 3 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | ||||||
| Inventory Net | 4 | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 7 | 8 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | ||||||
| Assets Current | 8 | 8 | 9 | 8 | 8 | 8 | 7 | 6 | 6 | 8 | 11 | 11 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Finite Lived Intangible Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 15 | 15 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 14 | 17 | 17 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Lines Of Credit Current | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | ||||||
| Long Term Debt Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | - | 1 | - | - | - | - | - | - | - | ||||||
| Accounts Payable Current | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | ||||||
| Accrued Salaries Current | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | ||||||
| Defined Benefit Pension Plan Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 8 | 8 | 9 | 7 | 6 | 6 | 6 | 5 | 6 | 6 | 7 | 9 | ||||||
| Convertible Subordinated Debt Noncurrent | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Operating Lease Liability Noncurrent | 4 | 4 | 1 | - | 1 | - | - | - | - | - | - | - | ||||||
| Other Long Term Debt Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 0 | ||||||
| Liabilities | 14 | 14 | 11 | 9 | 9 | 8 | 8 | 10 | 10 | 11 | 12 | 11 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 32 | 32 | 32 | 32 | 32 | 31 | 31 | 30 | 30 | 28 | 28 | 28 | ||||||
| Retained Earnings Accumulated Deficit | -30 | -30 | -30 | -28 | -27 | -26 | -26 | -28 | -27 | -25 | -23 | -22 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Stockholders Equity | 1 | 1 | 1 | 2 | 3 | 4 | 3 | 2 | 1 | 3 | 4 | 5 | ||||||
| Liabilities And Stockholders Equity | 15 | 15 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 14 | 17 | 17 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | 0 | 0 | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 25 | 50 | 50 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Common Stock Shares Issued | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 10 | 10 | 10 | ||||||
| Shares Outstanding | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 10 | 10 | 10 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBLONDER TONGUE LABORATORIES INC (BDRL) — SEC Financial Statements & Analysis
BLONDER TONGUE LABORATORIES INC (BDRL) is a radio & tv broadcasting & communications equipment company, incorporated in DE. BLONDER TONGUE LABORATORIES INC trades on OTC as: BDRL. BLONDER TONGUE LABORATORIES INC (BDRL)'s most recent SEC filing is a Form 10-K for the period ended 2022-12-31, filed with the SEC on 2023-04-17. Based on its latest SEC filing (Form 10-Q, period ending 2022-12-31), On profitability, BLONDER TONGUE LABORATORIES INC posts a gross margin of 30.16%, an operating margin of -18.13%, a net margin of -22.49%, a Return on Equity (ROE) of -186.92%, a Return on Assets (ROA) of -30.27%, and a Return on Invested Capital (ROIC) of -60.57%. Per share, it reports EPS of $-0.31, diluted EPS of $-0.31, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 14.99% year-over-year, net income growth of -4950.00% year-over-year, and EPS growth of -4537.34% year-over-year. On the balance sheet, it maintains a current ratio of 0.98x, a quick ratio of 0.43x, working capital of $-188.00K, a debt-to-equity ratio of 12.97x, a debt ratio of 0.93, an interest coverage ratio of -4.33x, free cash flow of $-1.43M (TTM), and net debt of $4.38M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.31
- ROE TTM
- -186.92%
- ROA TTM
- -30.27%
- Debt To Equity
- 12.97x
- Free Cash Flow TTM
- $-1.43M
- Net Revenue TTM Growth 1Y
- 14.99%
Data as of 2022-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BLONDER TONGUE LABORATORIES INC in?
BLONDER TONGUE LABORATORIES INC (BDRL) operates in the Radio & Tv Broadcasting & Communications Equipment industry.
What exchange does BDRL trade on?
BLONDER TONGUE LABORATORIES INC (BDRL) trades on the OTC.
Where is BLONDER TONGUE LABORATORIES INC incorporated?
BLONDER TONGUE LABORATORIES INC is incorporated in DE.
When was BLONDER TONGUE LABORATORIES INC (BDRL)'s most recent SEC filing?
BLONDER TONGUE LABORATORIES INC (BDRL)'s most recent SEC filing is a Form 10-K for the period ended 2022-12-31, filed with the SEC on 2023-04-17.
What is BDRL's EPS (earnings per share)?
BLONDER TONGUE LABORATORIES INC (BDRL)'s trailing twelve month EPS is $-0.31 as of 2022-12-31.
What is BDRL's ROE (return on equity)?
BLONDER TONGUE LABORATORIES INC (BDRL)'s trailing twelve month Return on Equity (ROE) is -186.92% as of 2022-12-31.
What is BDRL's ROA (return on assets)?
BLONDER TONGUE LABORATORIES INC (BDRL)'s trailing twelve month Return on Assets (ROA) is -30.27% as of 2022-12-31.
What is BDRL's ROIC (return on invested capital)?
BLONDER TONGUE LABORATORIES INC (BDRL)'s trailing twelve month Return on Invested Capital (ROIC) is -60.57% as of 2022-12-31.